SafeToAct Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

SafeToAct General Information

Description

Provider of 3D replica model of human kidney. The company develops simulation models of human anatomy for medical training purposes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Products
Other Industries
Other Devices and Supplies
Primary Office
  • Raja 15
  • Mustamae
  • Harju Maakond, 12618
  • Estonia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SafeToAct Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view SafeToAct’s complete valuation and funding history, request access »

SafeToAct Executive Team (3)

Name Title Board Seat Contact Info
Maarja Kruusmaa Ph.D Co-Founder
Asko Ristolainen Ph.D Co-Founder, Production & Development
To view SafeToAct’s complete executive team members history, request access »

SafeToAct Board Members (1)

Name Representing Role Since
Peeter Ross Ph.D SafeToAct Co-Founder, Board Member and Mentor 000 0000
To view SafeToAct’s complete board members history, request access »

SafeToAct Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SafeToAct Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tehnopol Startup Incubator Accelerator/Incubator 000 0000 000000 0
To view SafeToAct’s complete investors history, request access »